Safety and efficacy of transjugular intrahepatic portosystemic shunt therapy for symptomatic portal biliopathy
Main Authors: | Feng Zhang, Xixuan Wang, Wei Zhang, Ming Zhang, Lei Wang, Yuzheng Zhuge |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Portal Hypertension & Cirrhosis |
Online Access: | https://doi.org/10.1002/poh2.54 |
Similar Items
-
Transjugular intrahepatic portosystemic shunt trends in China: A brief review
by: Xiao JiangQiang, et al.
Published: (2018-04-01) -
Overweight/Obesity Increases the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients
by: Lihong Gu, et al.
Published: (2023-04-01) -
Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
by: Long Huang, et al.
Published: (2015-01-01) -
Transjugular intrahepatic portosystemic shunt for portal hypertension in a patient with Caroli disease
by: Baoli Qi, et al.
Published: (2023-07-01) -
Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt
by: Yingying Li, et al.
Published: (2021-02-01)